visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Trevena, Inc

    Get Full Access

    Description

    • Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target G protein coupled receptors, or GPCRs. We are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. We have identified four biased ligand drug candidates: TRV130, an FDA-designated Breakthrough Therapy, is currently in phase 3 testing for the intravenous treatment of acute moderate to severe pain TRV027 was evaluated in a Phase 2b study for the treatment of acute heart failure TRV734 has completed phase 1 testing for oral treatment of acute and chronic pain; and TRV250 is in preclinical development for the treatment of migraine. In addition, Trevena has an early stage portfolio of drug discovery programs currently in lead optimization.
    • location

      Headquarters:955 Chesterbrook Boulevard Suite 110, Chesterbrook, Pennsylvania, United States

      More
    • Trevena, Inc phone

      Phone Number: +1 610-354-8840

    • Trevena, Inc website

      Website: https://www.trevenainc.com

    • Trevena, Inc employees

      Employees:55

    • Trevena, Inc revenue

      Revenue:$50 - 100M

    • Trevena, Inc legal name

      Legal Name:Trevena, Inc

    • Trevena, Inc's Social Media

      Trevena, Inc linkedin Trevena, Inc twitter
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    CEO for Trevena, Inc

    Carrie Bourdow

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Bob Yoder

    Senior Vice President And Chief Commercial Officer

    Mike Fossler

    Vice President

    Todd Wandstrat

    Vice President, Health Economics And Medical Sciences

    Angela Bagley

    Vice President Technical Operations

    Michael Kramer

    Vice President, Scientific Operations And Alliance Management

    Frequently Asked Questions regarding Trevena, Inc

    • Where are Trevena, Inc's Headquarters?

      Trevena, Inc's Headquarters are in 955 Chesterbrook Boulevard Suite 110,Chesterbrook,Pennsylvania,United States

    • What is Trevena, Inc's phone number?

      Trevena, Inc's phone number is +1 610-354-8840

    • What is Trevena, Inc's official website?

      Trevena, Inc's official website is https://www.trevenainc.com

    • What is Trevena, Inc's Revenue?

      Trevena, Inc's revenue is $50 - 100M

    • What is Trevena, Inc's NAICS code?

      Trevena, Inc's NAICS code is 325412

    • How many employees are working in Trevena, Inc

      Trevena, Inc has 55 employees

    • What is Trevena, Inc's Industry?

      Trevena, Inc is in the industry of Biotechnology

    • Who is Trevena, Inc's CEO?

      Trevena, Inc's CEO is Carrie Bourdow

    Company Directory